Chemed Corporation
The biggest 3000 companies in the U.S. in the year of 2025.
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
LowerRationale:
Chemed has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
N/ARationale:
Chemed does not publish charitable giving guidelines (1).
Criteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighRationale:
Chemed offers DEI training to its employees (1). The company appears to prioritize diversity over merit in its leadership composition. From its 2026 Proxy Statement: “The Nominating Committee considers diversity in identifying [board] nominees specifically including race, ethnicity and gender diversity” (2). Chemed does not provide viewpoint protections for its employees (3).
Corporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
HighRationale:
Chemed supports DEI within its business practices. From its 2025 Annual Report: “Maintaining a diverse and inclusive workforce is necessary to continue our success. Diverse perspectives help foster continued innovation. Moreover, as a provider of services, our businesses understand that a diverse and inclusive workforce is necessary to best identify and build relationships with our equally diverse customers and patients. Both Roto-Rooter and VITAS highly value diversity in their workplaces and have established and maintained diverse workforces that are constantly evolving to better resemble the communities and populations that we serve” (1). The company supports ESG within its business practices. From its 2025 ESG Report: “In advance of preparing this [ESG] Report and our SASB Matrix, the Company conducted a materiality assessment in 2024 to identify our most significant sustainability impact areas. We engaged with internal and external stakeholders to determine topics of importance that are likely to impact our businesses” (2).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
Chemed has not used corporate funds to advance ideological causes, organizations, or policies (1).